Teva Wins Pause Of Order Ousting Patents From Orange Book

By Carla Baranauckas · June 13, 2024, 6:04 PM EDT

A New Jersey federal judge ordered on Thursday a 30-day stay of his Monday ruling that a handful of patents covering Teva-brand asthma inhalers were improperly listed in the federal Orange...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al

Case Number

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

October 06, 2023

Recent Articles By Carla

July 01, 2024
NJ Hospital Dodges $14.7M In Damages Over Audits
June 26, 2024
NJ Panel Tosses Malpractice Suit Over COVID-19 Death
June 24, 2024
Justices Pass On Rutgers COVID-19 Vax Mandate Case
June 18, 2024
Fla. Immune To Contract Suit Over COVID Tests, 4th Circ. Says
June 12, 2024
Lies At Heart Of Fraud Case Over COVID Test Kits, Jurors Told
June 11, 2024
Retrial Begins In NJ Fraud Case Over COVID Test Kit Deal
June 04, 2024
Fox Rothschild Partner Can't Testify In NJ Fraud Retrial
April 29, 2024
Sandoz Says Biopharma Biz Added 'Poison' To Market
April 23, 2024
Feds Seek To Bar Fox Rothschild Atty From Fraud Retrial
February 26, 2024
NJ Town Justified Hospital-Only Zone, Appeals Panel Says